European Pharmaceutical Review

AUGUST 23, 2022

1 Simply, pharmaceutical products are the most vulnerable to counterfeiting. 1 Simply, pharmaceutical products are the most vulnerable to counterfeiting. One of the highest protections is to implement on- or in-dose authentication that allows patients to play a key role in combatting illicit pharmaceutical products.

Dosage 87

Dosage Packaging Pharmaceutical Companies Pharmaceutical Companies 87

ISPE

NOVEMBER 1, 2022

Vice President, Vetter Development Service, External Affairs. 2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Trudy Patterson. Tue, 11/01/2022 - 06:49. iSpeak Blog. 2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Susan Sandler. 1 November 2022.

FDA 98

FDA Insurance Chemotherapy Documentation 98

ISPE

NOVEMBER 2, 2022

Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Vice President, Hospital Business Unit Global Supply Chain.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

Pharmaceutical Technology

NOVEMBER 11, 2022

Investment in AI-based research and development, and a focus on the major diseases that affect people in Africa could facilitate the domestic pharmaceutical industry’s growth and reduce the dependence on imports, experts said at a recent event.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

JUNE 6, 2023

Shots: Driven by the influx of life-changing innovations and technological advances, the pharmaceutical industry is forging ahead at a momentous pace. The article focuses on the integration of automation with Artificial Intelligence (AI) and Machine Learning (ML). How Important are AI & ML for Pharmaceutical Industry?

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Mayo Clinic Data Entry 40

European Pharmaceutical Review

SEPTEMBER 2, 2022

This article explores just one aspect of the RMP, that of RMMs, and how their effectiveness is measured with Dr Sophie Jouaville, an associate principal at IQVIA working on the design and oversight of non-interventional real-world evidence (RWE) safety and health economics and outcomes research (HEOR) studies.

Adverse Reactions 71

Adverse Reactions Documentation Medical Schools Packaging 71

ISPE

JUNE 27, 2023

The session included regulators from the European Medicines Agency (EMA), the UK Medicines & Healthcare Products, Regulatory Agency (MHRA), the Spanish Agency of Medicines and Medical Products (AEMPS) and the US Food and Drug Administration (FDA). In answer to the question, what does the industry have to do?

Communication 52

Communication FDA Vaccines 52

The Thyroid Pharmacist

FEBRUARY 17, 2023

Research has shown that NAC helps to reduce thyroid antibodies. In this article, I’ll cover: What NAC is Why NAC is important for detoxification How NAC supports people with Hashimoto’s How NAC affects oxidative stress and chronic inflammation How to incorporate NAC into your routine What is NAC?

FDA 98

FDA Immunization Dosage Compounding 98

PharmaShots

APRIL 10, 2023

Shots: With an incurable nature and hefty medication costs, diabetes mellitus remains a global health concern and the seventh leading cause of death across the world. Moreover, the ceaseless trials of pharmaceutical companies in the research of drugs for several disease conditions have transformed the course of therapeutics.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Hospitals 40

pharmaphorum

JUNE 28, 2022

As the article suggests, what could lie ahead is a process of learning how to live with a persistent circulation of the virus and, with this, consistent spikes of cases, likely occurring periodically and more often in the winter months. Research has suggested that in any given year there is a 2.5 Global governance.

Vaccines 52

Vaccines 52

ISPE

NOVEMBER 3, 2022

Director, Center for Biologics Evaluation and Research. The regulatory keynote was delivered by Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research (CBER), US FDA. Challenges of individualized therapies include manufacturing, nonclinical development, clinical development, and product access.

Communication 98

Communication FDA Documentation Vaccines 98

The Thyroid Pharmacist

JUNE 16, 2023

I’m always on the lookout for new research that could point us toward another tool to help us on our healing journeys. It’s actually considered a galactagogue, which means it can help to increase milk supply. [1] One Root Cause Reset member recommended it for seasonal allergies. I also found that my voice was becoming more hoarse.

Dosage 111

Dosage Compounding Immunization Insurance 111

European Pharmaceutical Review

FEBRUARY 7, 2023

Changes have been spurred by the COVID-19 pandemic, which emphasised the need to urgently modernise outdated EU pharmaceutical law and revise regulatory ambitions in the MedTech sector. Some of the current and anticipated proposals will not be adopted in 2023, or even before the end of tenure of the current European Commission in late 2024.

Packaging 91

Packaging 91

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Insurance Vaccines 56

Roots Analysis

DECEMBER 29, 2023

Clinical trials are prospective biomedical research studies designed to evaluate medical, surgical or behavioral interventions in people and investigate novel approaches for the diagnosis and prevention / treatment of diseases. Clinical research can be classified into two types: observational studies and clinical trials.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Adverse Reactions 40

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Organic compounds are arguably the foundation of the pharmaceutical industry.

Compounding 71

Compounding Pharmaceutical Companies Pharmaceutical Companies Packaging 71

ISPE

MARCH 8, 2023

This article proposes recommendations for industry and RAs to address the identified problems. This article proposes recommendations for industry and RAs to address the identified problems. Reports of contaminated products from multiple sources worldwide were gathered to review overall trends and identify challenges. March 2020.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

pharmaphorum

JANUARY 5, 2021

In the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that will affect the global healthcare and pharmaceutical industries in 2021. One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

SEPTEMBER 3, 2020

In this article, I reflect on how the three COVID crises are reshaping the way in which innovative pharmaceutical companies engage with all their customers, and in particular how they consider their commercial models and innovative launch strategies. But that doesn’t mean we are completely flying blind.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies 97

ISPE

SEPTEMBER 11, 2023

Cauchon, PhD 1 September 2023 The biopharmaceutical industry must develop and implement innovative ways of working to be effective and efficient in the current healthcare ecosystem, in which high-quality medicines, adaptability, and assurance of supply are of critical importance.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

FEBRUARY 1, 2023

Recent advancements in bioreactor automation have improved lab efficiency and provided a critical experimental advantage in early discovery and process development work. Next, building code limitations exert a considerable challenge in providing a continuous and reliable high-purity oxygen supply for bioreactors.

Communication 97

Communication 97

ISPE

MAY 11, 2023

Implementing and validating a new process, or maintaining the validation status during process changes, is a requirement of the pharmaceutical industry. The ML-analyzed data provides the evidence for validation of the change by demonstrating more control over the process along with a decrease in process risks. The Validation 4.0

Documentation 52

Documentation Labelling FDA 52

ISPE

JULY 6, 2023

This article provides a review on the current state of CM implementation, offers insights into life cycle management and regulatory aspects, and explains how a data- and knowledge-centric approach to risk management can help CM achieve its full potential. It is recognized as a key process intensification approach.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MARCH 6, 2023

Challenges for Net Zero Carbon Pharmaceutical Manufacturing Trudy Patterson Mon, 03/06/2023 - 12:40 Features March / April 2023 Challenges for Net Zero Carbon Pharmaceutical Manufacturing Keith M. 1 Intergovernmental Panel on Climate Change (IPCC). Sixth Assessment Report: Climate Change 2021: The Physical Science Basis.”

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

SEPTEMBER 8, 2023

The scope includes innovations in modalities, modes of delivery and administration of medicines, pharmaceutical manufacturing and analytical technology, and digital transformation. However, significant barriers exist for the global implementation of new, innovative technology for chemistry, manufacturing, and controls (CMC).

FDA 52

FDA Dosage Documentation Communication 52

ISPE

MARCH 7, 2023

This article reviews two case studies that cover sustainable pack types and extension of shelf life. With the drive to manage unmet medical need through acceleration of drug development programs, postapproval sustainability variations will always be required. 1 Now there’s an additional focus: sustainability.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

ISPE

MARCH 7, 2023

Melton, PhD 1 March 2023 The imperative for global action to tackle climate change is clear and the pharmaceutical industry has a key role to play. 1 , 2 The effect to the pharmaceutical industry spans its end-to-end activities, including the residual impact of used and unused medicines on the environment. 1 United Nations.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MARCH 29, 2023

3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. link] 2 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. link] 2 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Documentation 52

Documentation Dosage Packaging Communication 52

The Thyroid Pharmacist

OCTOBER 6, 2023

Then in pharmacy school, I learned about how psychiatric medications have histamine-blocking properties as well. Thus, this article was due for an update, as it was initially published in 2019. My hope is that this article provides you with helpful information, clarity, and next steps in your own journey of discovery.

Health and Personal Care Stores 82

Health and Personal Care Stores Immunization Dosage Compounding 82

The Thyroid Pharmacist

JULY 20, 2023

I commonly see iron deficiency – with its symptoms of fatigue, restless legs, insomnia, cold intolerance, moodiness, and the upsetting “thyroid” hair loss results – in many of my clients, even after they start thyroid medications like levothyroxine, Synthroid, and even Tirosint. Get more iron in your diet and/or take an iron supplement!

Health and Personal Care Stores 61

Health and Personal Care Stores HIV Treatment and Prevention Agents Insurance Immunization 61

ISPE

AUGUST 29, 2022

Postapproval change management of pharmaceuticals is an essential part of life-cycle management but is associated with regulatory challenges. The resulting complexity requires manufacturers to tightly control and manage supply chain activities for commercial products globally to maintain compliance.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

MAY 10, 2023

1 May 2023 Funded by the European Commission from 2019, the Smart Pharmaceutical Manufacturing Project (SPuMoNI) 1 harnesses the potential of state-of-the-art technologies for the pharmaceutical industry. This article discusses the main SPuMoNI accomplishments. 1 Smart Pharmaceutical Manufacturing. SPuMoNI homepage.

Dosage 52

Dosage Chemotherapy Documentation Labelling 52

ISPE

JANUARY 10, 2023

Cauchon, PhD William Garden Jessica Molek Melissa Holstein, PhD James Angelo Chris Gallo Daniel LaCasse Glen Bolton 1 January 2023 Pandemic-related supply chain shortages have placed constraints on the supply of essential filters and chromatography resins.

Packaging 52

Packaging FDA Communication Vaccines 52

The Thyroid Pharmacist

JANUARY 13, 2023

Patients may initially report feeling more energetic after starting thyroid hormones, but this is usually followed by feeling worse and worse… until they are right back to where they were before they started the thyroid medications. In this article, I’ll discuss: What is the connection between thyroid issues and adrenal dysfunction?

Health and Personal Care Stores 98

Health and Personal Care Stores Insurance Communication Dosage 98

ISPE

OCTOBER 27, 2022

C sponsors currently address numerous emerging pharmaceutical entities, as well as manufacturing platforms, modes, and scale. This article discusses types of facilities and design considerations for C>. For such reasons, a number of viral vector (VV) systems are currently in place, with many other gene-vector systems in development.

Packaging 52

Packaging Communication Immunization Vaccines 52